Metformina Teva Italia (Metformin Hydrochloride)

Metformin works mainly by inhibiting mitochondrial complex I, which suppresses hepatic gluconeogenesis. The drug also increases peripheral glucose uptake and improves insulin signaling, leading to lower circulating glucose levels. Additional effects on intestinal glucose absorption and gut microbiota contribute to its overall antidiabetic activity.

The dose of metformin is individualized by the prescribing clinician based on the patient’s clinical condition, renal function and response to therapy. The prescriber determines the appropriate starting dose, titration schedule and maximum daily amount, following local prescribing guidelines.

Safety data for metformin in pregnancy are limited, and the drug is classified as pregnancy category unknown. Clinicians must weigh potential benefits against possible risks and consider alternative treatments when appropriate. Metformin is excreted in breast milk, so breastfeeding mothers should discuss continuation with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metformin belongs to the biguanide class and is generally preferred as first‑line therapy because it does not cause hypoglycaemia when used alone and may aid modest weight loss. In contrast, sulfonylureas stimulate insulin release and carry a higher risk of hypoglycaemia and weight gain.

Metformina Teva Italia should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in humid or excessively hot environments.

The medication is taken orally, usually with meals to minimise gastrointestinal discomfort. Tablets should be swallowed whole with a glass of water; they are not intended for crushing, chewing or splitting unless specifically advised by a healthcare professional.

The most serious adverse events are lactic acidosis, a rare but life‑threatening condition, and severe skin reactions such as Stevens‑Johnson syndrome. Early signs of lactic acidosis include unexplained fatigue, muscle pain, abdominal discomfort, rapid breathing or a feeling of coldness. Prompt medical attention is essential if these symptoms appear.

Metformina Teva Italia is contraindicated in patients with severe renal impairment (eGFR < 30 mL/min/1.73 m²), known hypersensitivity to metformin, acute or chronic metabolic acidosis, and those receiving radiographic contrast studies that may affect kidney function. Clinicians should also avoid use in individuals with uncontrolled heart failure.